Scorpion venom pieces slowed cancer cells in lab tests
Original title: Antitumor activity of scorpion venom-derived peptides: A meta-analysis of preclinical studies.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This was only done in lab dishes and in animals, not in people.
The short version
Researchers looked at 27 studies that tested tiny pieces of scorpion venom on cancer cells and in animals.
What was studied. Researchers gathered 27 published studies from 2015 to 2026. The studies tested small pieces of scorpion venom, called peptides, on cancer cells in dishes and in animals. The cells came from several cancers, including glioblastoma: The fastest-growing type of glioma (grade 4). Treatment usually starts soon after diagnosis: surgery first, then radiation and chemotherapy. See the glossary, a brain cancer.
What they found. Put together, the studies showed that these peptides lowered how many cancer cells stayed alive. The effect was strongest on lung cancer cells. In animals, tumors got smaller. The peptides also changed genes and proteins that help cancer cells grow and stay alive.
What this means, and what it doesn't
What it could mean: For now, this is a lead for scientists, not a treatment. It says scorpion venom may hold useful starting points for future cancer drugs. Brain cancer cells were one of the types tested.
What it doesn't mean: This does not mean there is a new treatment. No people were treated in these studies. The work was done in dishes and in animals, which is the earliest stage of research. Many things that work in dishes and in mice do not work in people. This is not a cure, and it is not something a doctor can give you today. Please do not try venom products on your own.
Source: PubMed, August 21, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.